Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01166854 · ClinicalTrials.gov registry record
Characterization of Familial Myopathy and Paget Disease of Bone
A clinical trial of Muscle Disorder and Bone Disorder, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT01166854 is a study of Muscle Disorder and Bone Disorder that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01166854, a study of Muscle Disorder and Bone Disorder, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The researcher wants to explore the genetic causes of muscle disease. The researcher is particularly interested in muscle disorders that occur in combination with diseases of bone that appear to be passed on from generation to generation. Diffuse Optical Spectroscopy will measure the concentrations of blood, water, and lipids (fats, for example) in your tissues. This device essentially measures the color of tissues in order to determine tissue physiology (its physical and chemical processes).
Conditions Studied
Interventions
- DEVICE Diffuse Optical Spectroscopy
Study Locations (1)
California
- Hewitt Hall - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-06-18 |
| Est. Completion | 2030-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01166854
The ClinicalTrials.gov registry entry for NCT01166854 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Muscle Disorder appearing as the primary indexed condition, and to 1 intervention - of which Diffuse Optical Spectroscopy is the first listed.
NCT01166854 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01166854 about?
NCT01166854 is a clinical study titled "Characterization of Familial Myopathy and Paget Disease of Bone". The researcher wants to explore the genetic causes of muscle disease. The researcher is particularly interested in muscle disorders that occur in combination with diseases of bone that appear to be passed on from generation to generation. Diffuse Optical Spectroscopy will measure the concentrations...
What is the current status of trial NCT01166854?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2010-06-18. Estimated completion is 2030-06.
What conditions does trial NCT01166854 study?
This clinical trial studies the following conditions: Muscle Disorder, Bone Disorder.
What interventions are being tested in trial NCT01166854?
The interventions under investigation include: Diffuse Optical Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT01166854?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01166854 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.